EAVI2020 EAVI2020 on Twitter EAVI2020 on Facebook EAVI2020 on LinkedIn

Professor Tomáš Hanke speaks to Scientia about innovative methods in vaccine design and development to combat HIV.

graphic illustration of red blood cells around a HIV virus cell

Prof Hanke, EAVI2020 PI at the University of Oxford spoke to Scientia which included his work on T cell response to second-generation conserved immunogen, HIVconsvX, and its predecessor, HIVconsv. Scientia is a popularised outreach journal that provides researchers with a platform to communicate their findings to others outside their speciality. Technical nomenclature is often transcribed into easier formats allowing further reach of the scientific outputs for maximising social impact, and engaging stakeholders.

Read the full article at the Scientia website.

Professor Tomáš Hanke – Use of Experimental Medicine for Rational Development of an Effective HIV Vaccine

Aug 12, 2020 | BiologyHealth and Medicine

Reference
https://doi.org/10.33548/SCIENTIA538

screenshot of Scientia article on website

Latest Posts

students sitting in a classroom
EAVI2020 9th PhD…
September 24, 2020
screenshot of the EAVI2020 august newsletter 2020
EAVI2020 quarterly…
August 27, 2020
EAVI2020 Students in…
August 27, 2020